EXPERIMENTAL STUDY ON THE CHANGES OF SPHINGOSINE 1-PHOSPHATE AND MATRIX METALLOPROTEINASES IN SERUM OF PATIENTS WITH OSTEOARTHRITIS

Author(s)

Liu D1, Yang H2, Wang Z2
1Xi'an NO.5 hospital, xi'an, China, 2Xi’an Jiaotong University Hospital, xi'an, China

OBJECTIVES : Osteoarthritis (OA) is a chronic, progressive, degenerative joint disease. The pathogenesis of osteoarthritis (OA) is not clear. Although 1-phosphate sphingosine (S1P) plays an important role in arthritis, its effect on osteoarthritis remains unknown. Matrix metalloproteinases 3(MMP3)has been found in recent years in articular cartilage disease, chronic synovial inflammation and autoimmune diseases,were significantly increased. This study is to explore how S1P affects MMP3 and leads to osteoarthritis (OA).

METHODS : RESULTS : The serum levels of S1P (0.149 ± 0.037 pg / ml) and MMP3 (225.79 ± 29.70 pg / ml) in the early OA group were significantly higher than S1P (0.065 ± 0.026 pg / ml) and MMP3 (59.62 ± 19.38 pg / ml) in the control group, the difference was statistically significant (P <0.05).In the Spearman's correlation analysis, S1P was found to be positively associated with serum levels of MMP-3(R =0.722, P <0.01).

CONCLUSIONS : levels of S1P and MMP3 may increase in the early stage of OA. S1P caused a significant increase in MMP3 levels and lead to OA.

Conference/Value in Health Info

2018-05, ISPOR 2018, Baltimore, MD, USA

Value in Health, Vol. 21, S1 (May 2018)

Code

PMD5

Topic

Epidemiology & Public Health

Topic Subcategory

Disease Classification & Coding

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×